Media Advisory - Oncolytics Biotech Inc. (ONC.TO) to Present at Bank of America (BAC) Merrill Lynch Health Care Conference
5/14/2013 7:03:45 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Director Election Results from its Annual and Special Meeting of Shareholders
5/13/2013 7:31:37 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces First Quarter 2013 Results
5/9/2013 6:53:12 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Details of 2013 Annual and Special Meeting of Shareholders
5/6/2013 6:30:19 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) to Present at 12th Annual Needham Healthcare Conference
4/29/2013 6:59:30 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Meets Primary Overall Statistical Endpoint in U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
3/28/2013 8:58:26 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO)'s Lung Cancer Drug Meets Main Goal of Mid-Stage Study
3/28/2013 7:39:15 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces 2012 Year End Results
3/14/2013 7:09:34 AM
More...
|
Oncolytics Biotech Inc. (ONC.TO) Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer
3/5/2013 9:44:37 AM
More...
|
Media Advisory - Oncolytics Biotech Inc. (ONC.TO) to Present at RBC Capital Markets 2013 Healthcare Conference
2/26/2013 6:16:15 AM
More...
|
|